Biomimetic virus-like mesoporous silica nanoparticles improved cellular internalization for co-delivery of antigen and agonist to enhance Tumor immunotherapy

Abstract

Nanocarrier antigen-drug delivery system interacts specifically with immune cells and provides intelligent delivery modes to improve antigen delivery efficiency and facilitate immune progression. However, these nanoparticles often have weak adhesion to cells, followed by insufficient cell absorption, leading to a failed immune response. Inspired by the structure and function of viruses, virus-like mesoporous silica nanoparticles (VMSNs) were prepared by simulating the surface structure, centripetal-radialized spike structure and rough surface topology of the virus and co-acted with the toll-like receptor 7/8 agonist imiquimod (IMQ) and antigens oocyte albumin (OVA). Compared to the conventional spherical mesoporous silica nanoparticles (MSNs), VMSNs which was proven to be biocompatible in both cellular and in vivo level, had higher cell invasion ability and unique endocytosis pathway that was released from lysosomes and promoted antigen cross-expression. Furthermore, VMSNs effectively inhibited B16-OVA tumor growth by activating DCs maturation and increasing the proportion of CD8 + T cells. This work demonstrated that virus-like mesoporous silica nanoparticles co-supply OVA and IMQ, could induce potent tumor immune responses and inhibit tumor growth as a consequence of the surface spike structure induces a robust cellular immune response, and undoubtedly provided a good basis for further optimizing the nanovaccine delivery system.

ZIF-90-decorated silica nanoparticles with a spiky surface: a novel approach to drug delivery

“…38 Gao et al conducted histological evaluations, confirming clear tissue structures without evident abnormalities, injuries, or inflammation post-administration of silica nanoparticles. 41 These collective findings demonstrate the non-toxic nature of spiky SNP post-administration, emphasizing their promising diagnostic and therapeutic potential.…”

Virus-Shaped Mesoporous Silica Nanostars to Improve the Transport of Drugs across the Blood–Brain Barrier

“…The shape of NP plays a key role in the NP transport across the BBB. , Nowak et al demonstrated that the transport rate of polystyrene rods was about twice that of spheres in a microfluidic chip BBB model, with rod-shaped particles showing better transport across the BBB . Mimicking viruses in size, shape, and surface properties can facilitate NP uptake into cells, including neuronal types. − Moreover, Wang et al showed that virus-like MSiNP have high drug loading, longer circulation times, as well as higher internalization within HeLa and RAW264.7 cells . We have also shown that L-dopa-functionalized gold nanostars cross an in vitro model of the three-dimensional (3D) human-derived brain endothelial cells .…”

Immunological nanomaterials to combat cancer metastasis

“…120 Gao et al also prepared virus-like mesoporous silica nanoparticles and found that these nanoparticles could enhance the delivery of antigens and imiquimod to potentiate cancer immunotherapy. 121 These studies suggested that virus-like particles processed specific properties compared to traditional spherical particles. The virus-like particles are able to potentiate their interaction with various cells, including immune cells, and thus enhance immune responses.…”